Subscribe to Newsletter

Genetics and epigenetics

Diagnostics Genetics and epigenetics

A Day at the (sncRNA) Zoo

| Luke Turner

It’s tricky to distinguish between valid and false-positive miRNA biomarkers – but evolutionarily conserved genetic signatures in animals could help

Inside the Lab Biochemistry and molecular biology

Super Method Seeks Cancer's Kryptonite

| Jonathan James

The combination of genome-scale CRISPR experiments and powerful computational approaches has created a Cancer Dependency Map

Inside the Lab Genetics and epigenetics

Load Versus Response

| Jonathan James

Higher tumor mutational burden is linked to improved survival across multiple cancer types.

Diagnostics Genetics and epigenetics

IEM Identification

| Jonathan James

Combining metabolomics and DNA sequencing could be the key to discovering new inborn errors of metabolism in children.

Outside the Lab Profession

The Spice of Life

| Luke Turner

Genomic research has a diversity problem that could restrict the future effectiveness of precision medicine for minority groups

Diagnostics Genetics and epigenetics

The Right Dose for the Right Person

| Michael Schubert

New guidelines for CYPC29 genotyping ensure that the correct alleles are tested and patients are prescribed the correct doses of common drugs

Inside the Lab Technology and innovation

Solving the Big Problems

| Luke Turner

We speak to bioengineer Stephen Quake to learn about the noninvasive prenatal tests that have saved thousands of pregnant women’s lives

Diagnostics Biochemistry and molecular biology

A Disease With Many Faces

| David R. Hout

Triple-negative breast cancer is not a single entity, and understanding each patient’s molecular subtype can influence treatment and outcomes

Inside the Lab Precision medicine

Next-Generation Sequencing: Will It Really Replace Single-Gene Tests in Pathology Labs?

| Sponsored by Thermo Fisher Scientific

The move to in-house next-generation sequencing has resulted in time and tissue savings, and improved collaboration across cancer care specialties

Diagnostics Genetics and epigenetics

Circular RNA Makes Its Mark

| Jason Sherburn

A new detection method enhances circular RNA’s potential as a cancer biomarker and forms the basis of a new database

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register